IDH1 and glioblastoma: This was likely due to comparatively short survival times as well as the GBM dataset being the smallest among those included in this study, compounded by the lack of IDH1/2 and/or MGMT data in a considerable number of cases, which further reduced the number of patients available for multivariable analysis.